MicroRNA Market Growth Forecast Reaching $3.32 Billion By 2030 At 15.6% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The MicroRNA Market Between 2026 And 2030?
The microrna market size has expanded considerably in recent years. It is anticipated to increase from $1.57 billion in 2025 to $1.86 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 18.5%. This growth during the historical period is due to the rise in genomic research adoption, increasing demand for biomarker discovery, growth of pcr-based testing, expansion of cancer research programs, and rising use of ngs instruments.
The microrna market is projected to experience substantial growth over the coming years, with its valuation expected to reach $3.32 billion by 2030, expanding at a compound annual growth rate (CAGR) of 15.6%. This anticipated growth can be linked to factors such as the increasing clinical applications of microrna diagnostics, the growing adoption of personalized medicine, advancements in therapeutic microrna development, the broadening scope of infectious disease research, and increasing capital directed towards molecular assay technologies. Significant trends shaping the market during this period include the wider application of precision genomics, the utilization of AI for microrna expression analysis, an increase in cloud-based storage for sequencing data, greater automation within molecular diagnostics, and the integration of IoT into laboratory workflows.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15608&type=smp
What Key Factors Are Shaping The MicroRNA Market Landscape?
The rising incidence of cancer is anticipated to fuel the expansion of the microRNA market in the future. Cancer is defined as an intricate illness marked by uncontrolled cellular growth and multiplication, frequently resulting in the development of malignant tumors capable of invading adjacent tissues and metastasizing to distant organs, thereby presenting substantial health dangers. The surge in cancer cases stems from multiple contributors, such as an aging demographic, lifestyle choices like smoking and inadequate diet, environmental contaminants, and advancements in detection methods facilitating earlier diagnoses. MicroRNA is utilized in conjunction with conventional cancer treatments to boost drug efficacy and enhance patient results. Beyond therapeutic applications, miRNAs function as diagnostic and prognostic indicators, assisting in the identification of cancer types, forecasting disease progression, and tracking responses to treatment. For example, in May 2024, data from the National Cancer Institute, a US-based government agency, showed approximately 20 million new cases and 9.7 million cancer-related deaths annually in 2022, with projections suggesting 15.3 million deaths and 29.9 million new cases per year by 2040. Consequently, the growing number of cancer instances is propelling the growth of the microRNA market.
How Is The MicroRNA Market Broken Down By Segment Categories?
The microrna market covered in this report is segmented –
1) By Product: Instruments, Consumables
2) By Assay Type: Immunoassay, Next Generation Sequencing, MiRNA Arrays, Polymerase Chain Reaction (PCR) Based Arrays
3) By Application: Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Other Applications
4) By End User: Academic And Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Clinical Research Organizations
Subsegments:
1) By Instruments: Quantitative PCR Systems, Microarray Platforms, Next-Generation Sequencing (NGS) Systems, Real-Time PCR Instruments, Microrna Analyzers
2) By Consumables: MicroRNA Kits ( Extraction Kits, Detection Kits), PCR Reagents, Primers And Probes, Microarrays And Chips, RNA Sequencing Kits
What Market Trends Are Affecting The MicroRNA Market?
Leading companies in the microRNA market are concentrating on developing advanced solutions, such as miRNA probe customization services, to meet the specific needs of researchers and clinicians, enhance the accuracy of miRNA detection, and facilitate a broad range of applications. MiRNA probe customization services refer to specialized offerings from biotechnology and molecular biology companies that design and produce tailored probes for particular microRNAs (miRNAs) for diverse research and clinical uses. For instance, in September 2023, Abnova Corporation, a Taiwan-based biotech company, launched improved services for customizing miRNA probes, along with a new collection of cataloged miRNA probes, to cater to the varied requirements of academic, industrial, and research communities engaged in miRNA research. These probes play a vital role in identifying and precisely locating miRNAs, which are small, non-coding RNA molecules crucial for various biological processes. Abnova’s customization services ensure high specificity and minimal cross-reactivity, making them well-suited for analyzing samples with limited miRNA content.
Which Players Are Present In The MicroRNA Market Space?
Major companies operating in the microrna market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc, Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., HTG Molecular Diagnostics Inc.
Get The Full MicroRNA Market Report:
https://www.thebusinessresearchcompany.com/report/microrna-global-market-report
Where Is The MicroRNA Market Most Concentrated Geographically?
North America was the largest region in the microRNA market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microrna market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized MicroRNA Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/microrna-global-market-report
Browse Through More Reports Similar to the Global MicroRNA Market 2026, By The Business Research Company
Organic Skincare Market Report 2026
https://www.thebusinessresearchcompany.com/report/organic-skincare-global-market-report
Professional Skincare Market Report
https://www.thebusinessresearchcompany.com/report/professional-skincare-global-market-report
Skin Care Products Market Report
https://www.thebusinessresearchcompany.com/report/skin-care-products-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.